CAPITOL HILL CONSULTING GROUP

Lobbying for OCULAR THREPEUTIX · Biopharmaceutical company focused on therapies for the eye.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Medicare/Medicaid

Issues related to Medicare reimbursement for therapies of the eye.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.